News
	
	
	
		When and why to consider the diagnosis of myasthenia gravis in neurological practice, and what treatment options do we currently have?
Myasthenia gravis (MG) is a clinically heterogeneous disease characterized by fluctuating muscle weakness and fatigability that worsens after physical exertion or mental stress. Accurate diagnosis is essential because treatment can lead to permanent remission and full functional capacity of the patient.
			Sjögren's Syndrome as a Cause of Dry Eye Syndrome
					Primary Sjögren's syndrome represents a complex autoimmune disease primarily affecting glands with…
			
	
			Infographic and Commentary from Practice: Reasons and Pathways for Patients to Biological Treatment of Asthma
					For asthma patients with the most severe forms of the disease to access targeted biological…
			
	
			Subcutaneous pdC1-INH in Patients with Hereditary Angioedema in Real-World Practice
					Italian authors published a series of cases of patients with hereditary angioedema caused by C1 inhibitor...
			
	
			Efficacy and Safety of an Activated FXII Inhibitor in Preventing HAE Attacks
					Hereditary angioedema (HAE) is a rare, potentially life-threatening inherited disorder characterized...
			
	
			To what extent does the delay between symptom onset and diagnosis of AATD affect patient survival?
					The risk of chronic obstructive pulmonary disease (COPD) is increased, among other things, by a deficiency...
			
	
			Augmentation Therapy of Bronchiectasis Due to AATD – Case Report
					Alpha-1-antitrypsin deficiency (AATD) is a rare cause of bronchiectasis unrelated to cystic fibrosis....
			
	
			Pregnancy and Childbirth in a Woman with VWD − A Case Study
					Pregnancy and childbirth are relatively demanding periods and situations for women with von Willebrand...
			
	
			Benefits and Cost-Effectiveness of Superabsorbent Dressings in the Treatment of Venous Leg Ulcers
					A recent cost-effectiveness analysis based on German data showed that using superabsorbent…
			
	
			Brain implants can affect the human mind in a surprising way
					The technology company Neuralink, owned by Elon Musk, announced in December 2022 that it plans to…
			
	
Popular this week
- Vaccination Against Hepatitis A Has Been Most Neglected Among People With Liver Disease
 - How Is Adolescent Self-Harm Related to Addiction?
 - AI Searches for New Antibiotics in Animal Venoms
 - What Are the Links Between Gambling, Depression, and Feelings of Escape During Play?
 - AI-Powered Phishing: A Growing Threat to Healthcare